Bioequivalence and Bioavailability Forum 15:01 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

fedesalas
Junior

Costa Rica,
2018-09-12 17:46

Posting: # 19279
Views: 210
 

 Bio Batch Size [Design Issues]

Dear all,

The EMA says about the bio batch:

"Test product
The test product used in the study should be representative of the product to be marketed and this
should be discussed and justified by the applicant.
For example, for oral solid forms for systemic action:
a) The test product should usually originate from a batch of at least 1/10 of production scale or
100,000 units, whichever is greater, unless otherwise justified."


But if the bio batch used in the BE study was lower than 100 000 tablets, in what way we can justify this?
Ohlbe
Hero

France,
2018-09-13 00:19

@ fedesalas
Posting: # 19283
Views: 185
 

 Bio Batch Size

Dear fedesalas,

» For example, for oral solid forms for systemic action:
» a) The test product should usually originate from a batch of at least 1/10 of production scale or 100,000 units, whichever is greater, unless otherwise justified."
»
» But if the bio batch used in the BE study was lower than 100 000 tablets, in what way we can justify this?

If the intended production batch size is smaller than 100,000 units, then you have to use a full size batch. This may happen for drugs with a very small market: if you plan to have a production batch size of 50,000 because the sales are very limited (orphan drug product), then use this for your biobatch.

If the expected sales are millions of tablets per year, don't even think of claiming a batch size of 50,000 because that's what you used in your BE. It won't work. The Agencies won't believe you and your dossier is likely to get rejected. If the study has already been performed: too bad. Too late. The justification should come before the trial, not after...

Regards
Ohlbe
Back to the forum Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,700 posts in 3,984 threads, 1,243 registered users;
online 26 (0 registered, 26 guests [including 17 identified bots]).

I suppose it is tempting, if the only tool you have is a hammer,
to treat everything as if it were a nail.    Abraham Maslow

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed